Canada markets closed

Cipher Pharmaceuticals Inc. (CPHRF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
6.65-0.10 (-1.48%)
At close: 02:29PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 162.93M
Enterprise Value 123.46M
Trailing P/E 8.44
Forward P/E 14.84
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.11
Price/Book (mrq)2.02
Enterprise Value/Revenue 5.83
Enterprise Value/EBITDA 10.96

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 3181.25%
S&P500 52-Week Change 325.38%
52 Week High 37.37
52 Week Low 32.40
50-Day Moving Average 36.14
200-Day Moving Average 34.36

Share Statistics

Avg Vol (3 month) 321.12k
Avg Vol (10 day) 36.42k
Shares Outstanding 524.11M
Implied Shares Outstanding 624.14M
Float 822.57M
% Held by Insiders 144.51%
% Held by Institutions 11.12%
Shares Short (Nov 30, 2016) 411.43k
Short Ratio (Nov 30, 2016) 40.97
Short % of Float (Nov 30, 2016) 4N/A
Short % of Shares Outstanding (Nov 30, 2016) 40.04%
Shares Short (prior month Oct 31, 2016) 448.42k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 96.32%
Operating Margin (ttm)48.15%

Management Effectiveness

Return on Assets (ttm)8.06%
Return on Equity (ttm)28.19%

Income Statement

Revenue (ttm)21.16M
Revenue Per Share (ttm)0.85
Quarterly Revenue Growth (yoy)0.20%
Gross Profit (ttm)N/A
EBITDA 11.44M
Net Income Avi to Common (ttm)20.38M
Diluted EPS (ttm)0.80
Quarterly Earnings Growth (yoy)-61.10%

Balance Sheet

Total Cash (mrq)39.83M
Total Cash Per Share (mrq)1.66
Total Debt (mrq)353k
Total Debt/Equity (mrq)0.44%
Current Ratio (mrq)9.19
Book Value Per Share (mrq)3.36

Cash Flow Statement

Operating Cash Flow (ttm)16M
Levered Free Cash Flow (ttm)5.48M